ArticleBioinformatics (Oxford, England)2026
DeepPathway: predicting pathway expression from histopathology images.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
motivationSpatial transcriptomics (ST) technologies provide spatially resolved gene expression along with image data, allowing the integrative analysis of complex tissue microenvironment. Despite their potential, the widespread adoption of ST remains limited due to high costs, and methodological challenges in data acquisition. Thus, there have been recent efforts to develop deep learning methods for inferring spatial gene expression from much cheaper and easily available haematoxylin and eosin (H&E) images. These methods demonstrate promising results in reconstructing transcriptomic landscapes within tissue sections. While existing approaches focus on gene-level predictions, biological processes are often regulated at the pathway level through coordinated activity among functionally related genes.
resultsWe present DeepPathway, a contrastive learning-based approach trained on ST data to predict pathway expression from H&Es. We compute input pathway expression by summarizing the expression of constituent genes using established pathway definitions. We evaluate the performance of DeepPathway on multiple cancer datasets and validate it on the H&E images from The Cancer Genome Atlas (TCGA) clearly differentiating certain pathway activities in normal and tumour tissue regions. Finally, we apply our method to predict hypoxia signatures using H&Es of brain tumour samples where hypoxia staining with pimonidazole was available as ground truth. CODE AVAILABILITY: Implementation code for DeepPathway is available at https://doi.org/10.5281/zenodo.21100191 and at GitHub repository: https://github.com/aahsan045/DeepPathway.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.